We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+3.58%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$69.4B
AUM Growth
+$3.54B
Cap. Flow
+$1.44B
Cap. Flow %
2.08%
Top 10 Hldgs %
21.44%
Holding
3,843
New
225
Increased
1,690
Reduced
1,576
Closed
217

Sector Composition

Rank Sector Weight
1 Technology 10.52%
2 Financials 9.29%
3 Healthcare 8.12%
4 Industrials 6.67%
5 Consumer Discretionary 5.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AFL icon
301
Aflac
AFL
$62.6B
$42.9M 0.06%
781,894
-101,892
-12% -$5.25M
GLIBA
302
DELISTED
GCI Liberty, Inc. Class A Common Stock (DE)
GLIBA
$42.6M 0.06%
692,748
+59,824
+9% +$3.55M
DOW icon
303
Dow Inc
DOW
$21.2B
$42M 0.06%
+851,378
New +$44.9M
STWD icon
304
Starwood Property Trust
STWD
$6.09B
$41.8M 0.06%
1,840,680
-691,286
-27% -$15.7M
MAR icon
305
Marriott International
MAR
$92.3B
$41.7M 0.06%
297,313
-20,177
-6% -$2.68M
PK icon
306
Park Hotels & Resorts
PK
$2.97B
$41.5M 0.06%
1,505,980
-357,985
-19% -$10.7M
RNG icon
307
RingCentral
RNG
$5.28B
$41.3M 0.06%
359,084
+7,308
+2% +$842K
BR icon
308
Broadridge
BR
$19B
$40.9M 0.06%
320,182
+7,026
+2% +$846K
IYW icon
309
iShares US Technology ETF
IYW
$25.2B
$40.4M 0.06%
816,196
-60,172
-7% -$2.94M
LADR
310
Ladder Capital
LADR
$1.24B
$40.3M 0.06%
2,423,761
+95,626
+4% +$1.59M
CSX icon
311
CSX Corp
CSX
$93.1B
$40.1M 0.06%
1,554,366
+37,170
+2% +$958K
CMI icon
312
Cummins
CMI
$88.7B
$39.8M 0.06%
232,468
-13,170
-5% -$2.16M
FNB icon
313
FNB Corp
FNB
$6.75B
$39.7M 0.06%
3,370,469
-141,022
-4% -$1.63M
NTB icon
314
Bank of N.T. Butterfield & Son
NTB
$2.45B
$39.4M 0.06%
1,159,817
-35,333
-3% -$1.31M
DON icon
315
WisdomTree US MidCap Dividend Fund
DON
$4.09B
$39.4M 0.06%
1,087,691
+24,866
+2% +$893K
RPM icon
316
RPM International
RPM
$15B
$39.4M 0.06%
644,265
-24,515
-4% -$1.45M
RDS.B
317
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
$39.3M 0.06%
597,398
+21,099
+4% +$1.37M
ULTA icon
318
Ulta Beauty
ULTA
$24.3B
$39.1M 0.06%
112,769
+11,597
+11% +$4.01M
IGIB icon
319
iShares 5-10 Year Investment Grade Corporate Bond ETF
IGIB
$18.6B
$39M 0.06%
683,984
+189,608
+38% +$10.5M
SPSB icon
320
State Street SPDR Portfolio Short Term Corporate Bond ETF
SPSB
$10.7B
$38.9M 0.06%
1,263,486
+97,290
+8% +$2.97M
XEL icon
321
Xcel Energy
XEL
$48.8B
$38.3M 0.06%
642,974
-52,496
-8% -$3.02M
IEF icon
322
iShares 7-10 Year Treasury Bond ETF
IEF
$47.3B
$38.2M 0.06%
347,099
-687,416
-66% -$73.7M
CTXS
323
DELISTED
Citrix Systems Inc
CTXS
$38.2M 0.06%
388,749
-34,602
-8% -$3.39M
PAYX icon
324
Paychex
PAYX
$42.7B
$38M 0.05%
462,219
+25,330
+6% +$2.14M
CI icon
325
Cigna
CI
$74.6B
$37.9M 0.05%
240,640
+4,584
+2% +$718K

Similar funds

Raymond James & Associates's Q2 2019 Portfolio in Review

As of Q2 2019, Raymond James & Associates held 3,843 positions worth $69.4B, up 5.4% from $65.8B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Raymond James & Associates's Q2 2019 filing shows 225 new, 1,690 increased, 1,576 reduced and 217 closed positions. Its largest new stake was Dow Inc: 851,378 shares worth $42M. The largest sale was AbbVie, an estimated $134M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 11% a quarter earlier, followed by Financials and Healthcare.

  • Raymond James & Associates's largest Q2 2019 buy was Dow Inc: 851,378 shares worth $42M.
  • Raymond James & Associates added most to Medtronic in Q2 2019, an estimated $157M increase.
  • Raymond James & Associates's biggest Q2 2019 reduction was AbbVie, cutting an estimated $134M.
  • Raymond James & Associates fully exited Ultimate Software Group Inc in Q2 2019, selling an estimated $5.43M.
  • Raymond James & Associates's ten largest holdings make up 21% of its $69.4B portfolio in Q2 2019.
  • Raymond James & Associates opened 225 new positions and closed 217 in Q2 2019.
  • Raymond James & Associates's portfolio value rose 5.4% quarter-over-quarter to $69.4B.

Based on Raymond James & Associates's 13F filing for Q2 2019, filed 6 Aug 2019.